Teva CFO: Talks continue on US opioid compensation deal
Teva at the center of a lawsuit for raising drug prices - The Jerusalem Post
Israeli drugmaker Teva to cut quarter of global work force | Arab News
Exterior of the pharmaceutical manufacturing plant of Teva Pharmaceutical Industries located in Har Hotzvim also called Campus of Science-Rich Industries a high-tech industrial park located in northwest Jerusalem. Israel Stock Photo -
Teva Faces Rocky Path to Recovery After Debt | Fortune
A building belonging to Teva Pharmaceutical Industries, the world's biggest generic drugmaker and Israel's largest company, is seen in Jerusalem February 8, 2017. REUTERS/Ronen Zvulun Stock Photo - Alamy
Teva delays 33% of Jerusalem layoffs until 2019 - Israel News - The Jerusalem Post
Teva nears deal for Allergan's generic drugs unit: source | Reuters.com
In surprise move, Teva CEO Jeremy Levin steps down | The Times of Israel
Nobody Thought It Would Come to This': Drug Maker Teva Faces a Crisis - The New York Times
Pharmaceutical giant Teva to lay off employees at Israel branches - Israel News - The Jerusalem Post
Teva Pharmaceutical Initiated at Market Perform at BMO - TheStreet
The Teva-Allergan deal shows why pharma mergers are booming | Fortune
Teva Pharmaceuticals at heart of major price fixing suit in US - www.israelhayom.com
Teva workers blockade Jerusalem industrial park as PM, CEO set to meet | The Times of Israel
/cloudfront-us-east-2.images.arcpublishing.com/reuters/QWY4KJXSNVKQZH4U3JFZHKO74Q.jpg "Teva must face government's kickback claims over Copaxone - judge | Reuters")
Teva must face government's kickback claims over Copaxone - judge | Reuters
Teva's Recovery Hopes Mired in Staggering Antitrust Lawsuit, $26.7 Billion Debt | The Jewish Press - JewishPress.com | David Israel | 7 Iyyar 5779 – May 12, 2019 | JewishPress.com
Amid consternation in Israel, Teva shuts down Netanyahu's request to keep Jerusalem plant open | Fierce Pharma
Jerusalem, Israel. 21st Oct, 2019. The Teva Pharmaceutical logo is seen in English and Hebrew at their tablet production plant in Jerusalem, on Monday, October 21, 2019. The Israeli drug manufacturer Teva's
Levinstein's purchase of Teva's Jerusalem plant in doubt - Globes
Jewish Values Investors JLens Target Israeli Company
